Abraxis opens expanded plant in Phoenix, expected to create 200 jobs Nov 6, 2009
The company s drug, Abraxane, has received approval from the U.S. Food and Drug Administration and 38 other countries for treatment of metastatic breast cancer. It is in Phase III clinical trials for treatment of pancreatic, melanoma and lung cancer. (Phoenix Business Journal, AZ)
Abraxis Biosciences dedicates its new lab in Phoenix Nov 5, 2009
The lab will initially be used to make the company's Abraxane, a chemotherapy drug launched in 2005 to treat metastatic breast cancer. The firm is developing other drugs, too. (AZCentral -- Business)
Natco Pharma faces criminal action Oct 19, 2009
ALBUPAXa nanotechnology-based generic version of US company Abraxis BioSciences drug Abraxanehad hit the market in September 2008 after the clinical trial data were found satisfactory ... The original drug, Abraxane , is distributed in India through Biocon, but the drug is costlier than the Natco version by around Rs 5,000 per vial. (India Times)
Drugs Can Help Fight Breast Cancer Oct 7, 2009
The most popular breast cancer treatment drugs today are Femara, Tamoxifen, Abraxane, Zometa and Herceptin ... Abraxane is a chemotherapy injection that is used to treat breast cancer that has metastasized, or moved to other cells in the body ... Abraxane uses a natural human protein called albumin to transport the paclitaxel through the body instead of chemical catalysts like previous mitotic inhibitors. (Click2Houston, TX)
Ultra-tiny 'bees' target tumors Aug 19, 2009
There have already been two approved cancer treatments on the market that make use of nanoparticles: ovarian cancer drug Doxil, approved in 1995, and breast cancer drug Abraxane, approved in 2005. Both of these involve medication bound with nanoparticles that circulate in the bloodstream for longer than conventional drugs and are expected to migrate to the tumor site, Grodzinski said. (CNN)
Less-toxic Drug Prolongs Survival In Metastatic Breast Cancer May 28, 2009
A national study led by William Gradishar, M.D., director of breast medical oncology at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, found that the drug Abraxane prolonged progression-free survival by almost seven months compared with Taxotere, which is part of a class of solvent-based drugs called taxanes ... Abraxane uses albumin, a human protein, to deliver the chemotherapy ... The generic name for Abraxane is nab-paclitaxel. (Science Daily)
Drug May Extend Life When Breast Cancer Spreads May 28, 2009
Study funded by pharmaceutical company finds benefits in Abraxane ... TUESDAY, May 26 (HealthDay News) -- A new study affirms that the chemotherapy drug Abraxane is more effective, with less troublesome side effects, than the current drug of choice for metastatic breast cancer ... When compared with Taxotere, Abraxane extended the time before a recurrence by almost seven months, effectively doubling survival. (MEDLINEplus)
